Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2011 (2011), Article ID 152625, 12 pages
http://dx.doi.org/10.1155/2011/152625
Research Article

Lipopolysaccharide Inhibits the Channel Activity of the P2X7 Receptor

1Centro Fondap de Estudios Moleculares de la Célula Instituto de Ciencias Biomédicas, Facultad de Medicina, Universidad de Chile, Chile
2Section on Cellular Signaling, Program on Developmental Neuroscience (PDN), NICHD, Bethesda, Md, USA
3Departamento de Biología, Facultad de Química y Biología y Centro de Biotecnología Acuícola, Universidad de Santiago de Chile (USACH), Chile
4Facultad de Ciencias Biológicas y Facultad de Medicina, Universidad Andrés Bello, Chile
5Instituto de Química, Facultad de Ciencias, Pontificia Universidad Católica de Valparaíso PUCV, Avenida Universidad 330, Curauma, Valparaíso, Chile
6Centro de Regulación Celular y Patología J.V. Luco y Departamento de Fisiología, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Chile
7Departamento de Ciencias Básicas y Comunitarias, Facultad de Odontología, Universidad de Chile, Chile
8Emory Black, Facultad de Ciencias Médicas, Universidad de Santiago de Chile (USACH), Chile

Received 29 March 2011; Revised 3 June 2011; Accepted 20 June 2011

Academic Editor: Dennis Daniel Taub

Copyright © 2011 Elias Leiva-Salcedo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. F. Koch-Nolte, F. Haag, A. H. Guse, F. Lund, and M. Ziegler, “Emerging roles of NAD+ and its metabolites in cell signaling,” Science Signaling, vol. 2, no. 57, p. mr1, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  2. F. Haag, S. Adriouch, A. Braß et al., “Extracellular NAD and ATP: partners in immune cell modulation,” Purinergic Signalling, vol. 3, no. 1-2, pp. 71–81, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  3. R. A. North, “Molecular physiology of P2X receptors,” Physiological Reviews, vol. 82, no. 4, pp. 1013–1067, 2002. View at Google Scholar · View at Scopus
  4. A. Surprenant and R. Alan North, “Signaling at purinergic P2X receptors,” Annual Review of Physiology, vol. 71, pp. 333–359, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  5. P. Pelegrin and A. Surprenant, “Pannexin-1 mediates large pore formation and interleukin-1β release by the ATP-gated P2X7 receptor,” EMBO Journal, vol. 25, no. 21, pp. 5071–5082, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  6. L. Chen and C. F. Brosnan, “Regulation of immune response by P2X7 receptor,” Critical Reviews in Immunology, vol. 26, no. 6, pp. 499–513, 2006. View at Google Scholar · View at Scopus
  7. J. M. Labasi, N. Petrushova, C. Donovan et al., “Absence of the P2X7 receptor alters leukocyte function and attenuates an inflammatory response,” Journal of Immunology, vol. 168, no. 12, pp. 6436–6445, 2002. View at Google Scholar · View at Scopus
  8. F. Di Virgilio, “Liaisons dangereuses: P2X7 and the inflammasome,” Trends in Pharmacological Sciences, vol. 28, no. 9, pp. 465–472, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  9. L. Franchi, T. Eigenbrod, R. Muñoz-Planillo, and G. Nuñez, “The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis,” Nature Immunology, vol. 10, no. 3, pp. 241–247, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  10. C. Acuña-Castillo, C. Coddou, P. Bull, J. Brito, and J. P. Huidobro-Toro, “Differential role of extracellular histidines in copper, zinc, magnesium and proton modulation of the P2X7 purinergic receptor,” Journal of Neurochemistry, vol. 101, no. 1, pp. 17–26, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  11. C. Virginio, D. Church, R. A. North, and A. Surprenant, “Effects of divalent cations, protons and calmidazolium at the rat P2X7 receptor,” Neuropharmacology, vol. 36, no. 9, pp. 1285–1294, 1997. View at Publisher · View at Google Scholar · View at Scopus
  12. T. Takenouchi, M. Sato, and H. Kitani, “Lysophosphatidylcholine potentiates Ca2+ influx, pore formation and p44/42 MAP kinase phosphorylation mediated by P2X7 receptor activation in mouse microglial cells,” Journal of Neurochemistry, vol. 102, no. 5, pp. 1518–1532, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  13. Q. Zhao, M. Yang, A. T. Ting, and D. E. Logothetis, “PIP(2) regulates the ionic current of P2X receptors and P2X(7) receptor-mediated cell death,” Channels (Austin, Tex.), vol. 1, no. 1, pp. 46–55, 2007. View at Google Scholar · View at Scopus
  14. A. D. Michel, M. Xing, and P. Humphrey, “Serum constituents can affect 2′-& 3′-O-(4-benzoylbenzoyl)-ATP potency at P2X7 receptors,” British Journal of Pharmacology, vol. 132, no. 7, pp. 1501–1508, 2001. View at Google Scholar · View at Scopus
  15. R. Barbieri, S. Alloisio, S. Ferroni, and M. Nobile, “Differential crosstalk between P2X7 and arachidonic acid in activation of mitogen-activated protein kinases,” Neurochemistry International, vol. 53, no. 6–8, pp. 255–262, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  16. D. Ferrari, C. Pizzirani, E. Adinolfi et al., “The antibiotic polymyxin B modulates P2X7 receptor function,” Journal of Immunology, vol. 173, no. 7, pp. 4652–4660, 2004. View at Google Scholar · View at Scopus
  17. A. D. Michel and E. Fonfria, “Agonist potency at P2X7 receptors is modulated by structurally diverse lipids,” British Journal of Pharmacology, vol. 152, no. 4, pp. 523–537, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  18. E. Alzola, A. Pérez-Etxebarria, E. Kabré et al., “Activation by P2X7 agonists of two phospholipases A2 (PLA2) in ductal cells of rat submandibular gland: coupling of the calcium-independent PLA2 with kallikrein secretion,” Journal of Biological Chemistry, vol. 273, no. 46, pp. 30208–30217, 1998. View at Publisher · View at Google Scholar · View at Scopus
  19. M. A. Balboa, J. Balsinde, D. A. Dillon, G. M. Carman, and E. A. Dennis, “Proinflammatory macrophage-activating properties of the novel phospholipid diacylglycerol pyrophosphate,” Journal of Biological Chemistry, vol. 274, no. 1, pp. 522–526, 1999. View at Publisher · View at Google Scholar · View at Scopus
  20. L. C. Denlinger, P. L. Fisette, J. A. Sommer et al., “Cutting edge: the nucleotide receptor P2X7 contains multiple protein- and lipid-interaction motifs including a potential binding site for bacterial lipopolysaccharide,” Journal of Immunology, vol. 167, no. 4, pp. 1871–1876, 2001. View at Google Scholar · View at Scopus
  21. S. Li, H. Lu, X. Hu, W. Chen, Y. Xu, and J. Wang, “Expression of TLR4-MyD88 and NF-B in the iris during endotoxin-induced uveitis,” Mediators of Inflammation, vol. 2010, Article ID 748218, 7 pages, 2010. View at Publisher · View at Google Scholar · View at PubMed
  22. C. Acuña-Castillo, M. Aravena, E. Leiva-Salcedo et al., “T-kininogen, a cystatin-like molecule, inhibits ERK-dependent lymphocyte proliferation,” Mechanisms of Ageing and Development, vol. 126, no. 12, pp. 1284–1291, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  23. R. Fernández, G. Nardocci, F. Simon et al., “Lipopolysaccharide signaling in the carotid chemoreceptor pathway of rats with sepsis syndrome,” Respiratory Physiology and Neurobiology, vol. 175, no. 3, pp. 336–348, 2011. View at Publisher · View at Google Scholar · View at PubMed
  24. F. Aswad, H. Kawamura, and G. Dennert, “High sensitivity of CD4+CD25+ regulatory T cells to extracellular metabolites nicotinamide adenine dinucleotide and ATP: a role for P2X7 receptors,” Journal of Immunology, vol. 175, no. 5, pp. 3075–3083, 2005. View at Google Scholar · View at Scopus
  25. E. M. Pålsson-McDermott and L. A. J. O'Neill, “Signal transduction by the lipopolysaccharide receptor, Toll-like receptor-4,” Immunology, vol. 113, no. 2, pp. 153–162, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  26. R. Auger, I. Motta, K. Benihoud, D. M. Ojcius, and J. M. Kanellopoulos, “A role for mitogen-activated protein kinaseErk1/2 activation and non-selective pore formation in P2X7 receptor-mediated thymocyte death,” Journal of Biological Chemistry, vol. 280, no. 30, pp. 28142–28151, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  27. D. L. Donnelly-Roberts, M. T. Namovic, C. R. Faltynek, and M. F. Jarvis, “Mitogen-activated protein kinase and caspase signaling pathways are required for P2X7 receptor (P2X7R)-induced pore formation in human THP-1 cells,” Journal of Pharmacology and Experimental Therapeutics, vol. 308, no. 3, pp. 1053–1061, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  28. R. X. Faria, F. P. DeFarias, and L. A. Alves, “Are second messengers crucial for opening the pore associated with P2X 7 receptor?” American Journal of Physiology, vol. 288, no. 2, pp. C260–C271, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  29. L. Papp, E. S. Vizi, and B. Sperlágh, “P2X7 receptor mediated phosphorylation of p38MAP kinase in the hippocampus,” Biochemical and Biophysical Research Communications, vol. 355, no. 2, pp. 568–574, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  30. P. A. Verhoef, M. Estacion, W. Schilling, and G. R. Dubyak, “P2X7 receptor-dependent blebbing and the activation of Rho-effector kinases, caspases, and IL-1β release,” Journal of Immunology, vol. 170, no. 11, pp. 5728–5738, 2003. View at Google Scholar · View at Scopus
  31. J. Amstrup and I. Novak, “P2X7 receptor activates extracellular signal-regulated kinases ERK1 and ERK2 independently of Ca2+ influx,” Biochemical Journal, vol. 374, no. 1, pp. 51–61, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  32. M. Garcia-Marcos, E. Pérez-Andrés, S. Tandel et al., “Coupling of two pools of P2X7 receptors to distinct intracellular signaling pathways in rat submandibular gland,” Journal of Lipid Research, vol. 47, no. 4, pp. 705–714, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  33. M. Garcia-Marcos, S. Pochet, A. Marino, and J. P. Dehaye, “P2X7 and phospholipid signalling: the search of the “missing link” in epithelial cells,” Cellular Signalling, vol. 18, no. 12, pp. 2098–2104, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  34. L. C. Denlinger, J. A. Sommer, K. Parker et al., “Mutation of a dibasic amino acid motif within the C terminus of the P2X7 nucleotide receptor results in trafficking defects and impaired function,” Journal of Immunology, vol. 171, no. 3, pp. 1304–1311, 2003. View at Google Scholar · View at Scopus
  35. G. J. Brunn and J. L. Platt, “The etiology of sepsis: turned inside out,” Trends in Molecular Medicine, vol. 12, no. 1, pp. 10–16, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  36. A. Babelova, K. Moreth, W. Tsalastra-Greul et al., “Biglycan, a danger signal that activates the NLRP3 inflammasome via toll-like and P2X receptors,” Journal of Biological Chemistry, vol. 284, no. 36, pp. 24035–24048, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  37. C. A. Dinarello, “A signal for the caspase-1 inflammasome free of TLR,” Immunity, vol. 26, no. 4, pp. 383–385, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  38. T. D. Kanneganti, M. Lamkanfi, Y. G. Kim et al., “Pannexin-1-mediated recognition of bacterial molecules activates the cryopyrin inflammasome independent of Toll-like receptor signaling,” Immunity, vol. 26, no. 4, pp. 433–443, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  39. R. W. S. Li, R. Y. K. Man, P. M. Vanhoutte, and G. P. H. Leung, “Stimulation of ecto-5′-nucleotidase in human umbilical vein endothelial cells by lipopolysaccharide,” American Journal of Physiology, vol. 295, no. 3, pp. H1177–H1181, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  40. R. Utili, C. O. Abernathy, and H. J. Zimmerman, “Inhibition of Na+, K+-adenosinetriphosphatase by endotoxin: a possible mechanism for endotoxin-induced cholestasis,” Journal of Infectious Diseases, vol. 136, no. 4, pp. 583–587, 1977. View at Google Scholar · View at Scopus
  41. F. C. Vuaden, G. de Paula Cognato, C. Bonorino, M. R. Bogo, J. J. de Freitas Sarkis, and C. D. Bonan, “Lipopolysaccharide alters nucleotidase activities from lymphocytes and serum of rats,” Life Sciences, vol. 80, no. 19, pp. 1784–1791, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  42. R. Raouf, A. J. Chabot-Doré, A. R. Ase, D. Blais, and P. Séguéla, “Differential regulation of microglial P2X4 and P2X7 ATP receptors following LPS-induced activation,” Neuropharmacology, vol. 53, no. 4, pp. 496–504, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  43. R. L. Kitchens and R. S. Munford, “CD14-dependent internalization of bacterial lipopolysaccharide (LPS) is strongly influenced by LPS aggregation but not by cellular responses to LPS,” Journal of Immunology, vol. 160, no. 4, pp. 1920–1928, 1998. View at Google Scholar · View at Scopus
  44. J. A. Gegner, R. J. Ulevitch, and P. S. Tobias, “Lipopolysaccharide (LPS) signal transduction and clearance. Dual roles for LPS binding protein and membrane CD14,” Journal of Biological Chemistry, vol. 270, no. 10, pp. 5320–5325, 1995. View at Publisher · View at Google Scholar · View at Scopus
  45. R. Y. Hampton, D. T. Golenbock, M. Penman, M. Krieger, and C. R. H. Raetz, “Recognition and plasma clearance of endotoxin by scavenger receptors,” Nature, vol. 352, no. 6333, pp. 342–344, 1991. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  46. Y. H. Kang, R. S. Dwivedi, and C. H. Lee, “Ultrastructural and immunocytochemical study of the uptake and distribution of bacterial lipopolysaccharide in human monocytes,” Journal of Leukocyte Biology, vol. 48, no. 4, pp. 316–332, 1990. View at Google Scholar · View at Scopus
  47. J. Kriegsmann, S. Gay, and R. Bräuer, “Endocytosis of lipopolysaccharide in mouse macrophages,” Cellular and Molecular Biology, vol. 39, no. 7, pp. 791–800, 1993. View at Google Scholar · View at Scopus
  48. N. Thieblemont and S. D. Wright, “Transport of bacterial lipopolysaccharide to the Golgi apparatus,” Journal of Experimental Medicine, vol. 190, no. 4, pp. 523–534, 1999. View at Publisher · View at Google Scholar · View at Scopus
  49. C. Poussin, M. Foti, J. L. Carpentier, and J. Pugin, “CD14-dependent endotoxin internalization via a macropinocytic pathway,” Journal of Biological Chemistry, vol. 273, no. 32, pp. 20285–20291, 1998. View at Publisher · View at Google Scholar · View at Scopus
  50. Y. H. Kang, C. H. Lee, R. L. Monroy, R. S. Dwivedi, C. Odeyale, and H. H. Newball, “Uptake, distribution and fate of bacterial lipopolysaccharides in monocytes and macrophages: an ultrastructural and functional correlation,” Electron Microscopy Reviews, vol. 5, no. 2, pp. 381–419, 1992. View at Google Scholar · View at Scopus
  51. G. D. Kutuzova, R. M. Albrecht, C. M. Erickson, and N. Qureshi, “Diphosphoryl lipid A from Rhodobacter sphaeroides blocks the binding and internalization of lipopolysaccharide in RAW 264.7 cells,” Journal of Immunology, vol. 167, no. 1, pp. 482–489, 2001. View at Google Scholar · View at Scopus
  52. K. Niemi, L. Teirilä, J. Lappalainen et al., “Serum amyloid A activates the NLRP3 inflammasome via P2X7 receptor and a cathepsin B-sensitive pathway,” Journal of Immunology, vol. 186, no. 11, pp. 6119–6128, 2011. View at Publisher · View at Google Scholar · View at PubMed
  53. A. Elssner, M. Duncan, M. Gavrilin, and M. D. Wewers, “A novel P2X7 receptor activator, the human cathelicidin-derived peptide LL37, induces IL-1β processing and release,” Journal of Immunology, vol. 172, no. 8, pp. 4987–4994, 2004. View at Google Scholar · View at Scopus
  54. D. Ferrari, P. Chiozzi, S. Falzoni et al., “Extracellular ATP triggers IL-1β release by activating the purinergic P2Z receptor of human macrophages,” Journal of Immunology, vol. 159, no. 3, pp. 1451–1458, 1997. View at Google Scholar · View at Scopus
  55. I. P. Chessell, J. P. Hatcher, C. Bountra et al., “Disruption of the P2X7 purinoceptor gene abolishes chronic inflammatory and neuropathic pain,” Pain, vol. 114, no. 3, pp. 386–396, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  56. L. Chen and C. F. Brosnan, “Exacerbation of experimental autoimmune encephalomyelitis in P2X 7R-/- mice: evidence for loss of apoptotic activity in lymphocytes,” Journal of Immunology, vol. 176, no. 5, pp. 3115–3126, 2006. View at Google Scholar · View at Scopus
  57. D. G. Perregaux and C. A. Gabel, “Post-translational processing of murine IL-1: evidence that a tp- induced release of IL-1α and IL-1β occurs via a similar mechanism,” Journal of Immunology, vol. 160, no. 5, pp. 2469–2477, 1998. View at Google Scholar · View at Scopus
  58. A. E. Herman, G. J. Freeman, D. Mathis, and C. Benoist, “CD4+CD25+ T regulatory cells dependent on ICOS promote regulation of effector cells in the prediabetic lesion,” Journal of Experimental Medicine, vol. 199, no. 11, pp. 1479–1489, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  59. F. Aswad and G. Dennert, “P2X7 receptor expression levels determine lethal effects of a purine based danger signal in T lymphocytes,” Cellular Immunology, vol. 243, no. 1, pp. 58–65, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus